HA-29

HA-29 is an antiplatelet aggregation agent. HA-29 acts as a cyclooxygenase inhibitor and a thromboxane A2/prostaglandin endoperoxide receptor antagonist. HA-29 exerts its effects by inhibiting cyclooxygenase to block the formation of thromboxane A2 (TXA2), while simultaneously blocking the TXA2/prostaglandin endoperoxide receptor on platelets as a non-competitive antagonist. HA-29 can be used in antithrombotic research.

For research use only. We do not sell to patients.

  • CAS No.: 142733-19-5
  • Formula: C16H16N2O3
  • Molecular Weight:284.32
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All COX Isoforms

More

All Prostaglandin Receptor Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00